Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 21, Issue 4, 2008, Pages 321-328

  Schulte, Martina ^a   Osseiran, Karim ^b   Betz, Reiner ^c   Wencker, Marion ^d   Brand, Peter ^a   Meyer, Thomas ^a   Haidl, Peter ^b  

^a Inamed GmbH   (Germany)

^b KRANKENHAUS KLOSTER GRAFSCHAFT   (Germany)

^c GLAXOSMITHKLINE   (Germany)

^d Talecris Biotherapeutics GmbH   (Germany)

Author keywords

Asthma; COPD; Dry powder inhaler; Handling; Preference

Indexed keywords

ASMABEC; BECLOMETASONE DIPROPIONATE; BENOSID N; BUDENOSID RATIOPHARM; BUDESONIDE; CYCLOCAPS BUD; FLUTICASONE PROPIONATE; NOVOPULMON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRY POWDER; FEMALE; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

ADMINISTRATION, INHALATION; ADULT; AGED; ASTHMA; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 57149094554     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2007.0634     Document Type: Article

References (13)

1. Giraud V, and Roche N: Misuse of corticosteroid metereddose inhaler is associated with decreased asthma stability. Eur Respir J. 19:2002;246-251.
2. Boe J, Stiksa G, Svensson K, and Asbrink E: New method of evaluating patient preference for different inhalation delivery systems. Ann Allergy. 1992;68:255-260.
3. Burdon J, Droszcz W, Jones R, Johnston PR, and Trowell SJ: Comparison of efficacy and ease of handling of salmeterol and terbutaline powder inhalers. Int J Clin Pract. 1998; 52:85-88.
4. Eliraz A, Ramirez-Rivera A, Ferranti P, Holzer R, Garcia JM, Turcotte C, Rapatz G, Pfister P, Overend T, and Kottakis J: Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling. Int J Clin Pract. 2001;55:164-170.
5. Epstein S, Maidenberg A, Hallett D, Khan K, and Chapman KR: Patient handling of a dry-powder inhaler in clinical practice. Chest. 2001;120:1480-1484.
6. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, and Moore N: Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16:249-254.
7. Molimard M: How to achieve good compliance and adherence with inhalation therapy. Curr Med Res Opin. 2005;21(Suppl 4):S33-S37.
8. Price A, Rowland M, Aarons L, Bailey A, Williams W, Häußermann S, and Falcoz C: Computer lung modelling to predict inhaled particle deposition: A comparison of predicted and clinical data. J Aerosol Med. 1999;12:130.
9. Serra-Batlles J, Plaza V, Badiola C, and Morejon E: Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med. 2002;15:59-64.
10. Petro W, and Schuppenies A: Inhalation therapy by dose-inhalers: analysis of patients performance and possibilities for improvement. Pneumologie. 2005;59:316-320.
11. Berrade E, and Torrea S: [The handling of inhalers by bronchitis patients]. An Sist Sanit Navar. 1999;22:81-85.
12. Gracia-Antequera M, and Morales Suarez-Varela M: An intervention to improve the inhalatory technique of children and adolescents with asthma. Allergol Immunopathol (Madr). 1999;27:255-260.
13. Kesten S, Elias M, Cartier A and Chapman KR: Patient handling of a multidose dry powder inhalation device for albuterol. Chest. 1994;105:1077-1081.